The risk of hyponatremia with valproic acid, phenytoin, and topiramate is less understood and documented. The mechanism of ASMs-induced hyponatremia was shown to be due to an increased sensitivity to circulating AVP. This evidence concerns the gene AVP and Hyponatremia.